The pharmacological profile of norgestimate, a new orally active progestin
Hahn, D.W.; Allen, G.O.; McGuire, J.L.
Contraception 16(5): 541-553
1977
ISSN/ISBN: 0010-7824 PMID: 201429 DOI: 10.1016/0010-7824(77)90077-4Document Number: 434631
Document emailed within 0-6 h
Related Documents
Anderson, F.D. 1992: Norgestimate: a preclinical profile International Journal of Fertility 37(Suppl 1): 27-35Teichmann, A. 1995: Metabolic profile of six oral contraceptives containing norgestimate, gestodene, and desogestrel International Journal of Fertility and Menopausal Studies 40(Suppl 2): 98-104
Lippman, J. 1992: Long-term profile of a new progestin International Journal of Fertility 37(Suppl 4): 218-222
Menear, K. 1998: Progress towards the discovery of orally active thrombin inhibitors Current Medicinal Chemistry 5(6): 457-468
Kaplan, H.R.; Cohen, D.M.; Essenburg, A.D.; Major, T.C.; Mertz, T.E.; Ryan, M.J. 1984: CI-906 and CI-907: new orally active nonsulfhydryl angiotensin-converting enzyme inhibitors Federation Proceedings 43(5): 1326-1329
Sreenivasulu, S.; Singh, M.M.; Dwivedi, A.; Setty, B.S.; Kamboj, V.P. 1992: Duration of antiestrogenecity of compound CDRI-85/287: a new orally active nonsteroidal antiimplantation agent Indian Journal of Experimental Biology 30(11): 968-971
McClelland, D.L.; Rosenkranz, R.P. 1991: Antihypertensive, sympatholytic and renal effects of an orally active dopamine agonist, RS-12254 Proceedings of the Western Pharmacology Society 34: 135-140
Laffan, R.J.; Goldberg, M.E.; High, J.P.; Schaeffer, T.R.; Waugh, M.H.; Rubin, B. 1978: Antihypertensive activity in rats for SQ 14,225, an orally active inhibitor of angiotensin I-converting enzyme Journal of Pharmacology and Experimental Therapeutics 204(2): 281-288
Abe, Y.; Miura, K.; Imanishi, M.; Yukimura, T.; Komori, T.; Okahara, T.; Yamamoto, K. 1980: Effects of an orally active converting enzyme inhibitor (YS-980) on renal function in dogs Journal of Pharmacology and Experimental Therapeutics 214(1): 166-170
Handley, D.A.; Van Valen, R.G.; Melden, M.K.; Houlihan, W.J.; Saunders, R.N. 1988: Biological effects of the orally active platelet activating factor receptor antagonist SDZ 64-412 Journal of Pharmacology and Experimental Therapeutics 247(2): 617-623
Fagard, R.; Amery, A.; Lijnen, P.; Roussel-Deruyck, R. 1982: Discrimination of renovascular from essential hypertension by converting enzyme inhibition with an orally active compound Acta Clinica Belgica 37(1): 13-22
Chantot, J.F.; Mauvais, P. 1991: RU 51807 (cefpodoxime proxetil). in vitro and in vivo antibacterial activity of a new orally administered active cephalosporin Pathologie-Biologie 39(1): 17-27
Kumagai, A.; Tomioka, H.; Shida, T.; Takahashi, T.; Muranaka, M. 1980: Clinical evaluation of a new orally active anti-anaphylactic compound: ketotifen (HC 20-511) in Japanese adult asthmatics Schweizerische Medizinische Wochenschrift 110(6): 197-203
Boolell, M.; Allen, M.J.; Ballard, S.A.; Gepi-Attee, S.; Muirhead, G.J.; Naylor, A.M.; Osterloh, I.H.; Gingell, C. 1996: Sildenafil: an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction International Journal of Impotence Research 8(2): 47-52
Trapani, A.J.; De Lombaert, S.; Kuzmich, S.; Jeng, A.Y. 1995: Inhibition of big ET-1-induced pressor response by an orally active dual inhibitor of endothelin-converting enzyme and neutral endopeptidase 24.11 Journal of Cardiovascular Pharmacology 26(Suppl): S69-S71
Luffer-Atlas, D.; Vincent, S.H.; Painter, S.K.; Arison, B.H.; Stearns, R.A.; Chiu, S.H. 1997: Orally active inhibitors of human leukocyte elastase. III. Identification and characterization of metabolites of L-694,458 by liquid chromatography-tandem mass spectrometry Drug Metabolism and Disposition: the Biological Fate of Chemicals 25(8): 940-952
Yamazaki, M.; Asakura, H.; Aoshima, K.; Saito, M.; Jokaji, H.; Uotani, C.; Kumabashiri, I.; Morishita, E.; Ikeda, T.; Matsuda, T. 1994: Effects of DX-9065a, an orally active, newly synthesized and specific inhibitor of factor Xa, against experimental disseminated intravascular coagulation in rats Thrombosis and Haemostasis 72(3): 392-396
Humphries, H.; Osman, F.; Knight, L.; Abdool Karim, Q. 2019: Who is sexually active? Using a multi-component sexual activity profile (MSAP) to explore, identify and describe sexually-active high-school students in rural KwaZulu-Natal, South Africa Bmc Public Health 19(1): 317
Aono, J.; Koga, T.; Yamazaki, T.; Shiraki, Y.; Sakai, K. 1988: Antihypertensive action of a novel orally active angiotensin converting enzyme inhibitor altiopril calcium (MC-838) in several hypertensive models of rats: comparison with captopril Archives Internationales de Pharmacodynamie et de Therapie 292: 203-222
Verhagen, A.; Elsinga, P.H.; de Groot, T.J.; Paans, A.M.; de Goeij, C.J.; Sluyser, M.; Vaalburg, W. 1991: A fluorine-18 labeled progestin as an imaging agent for progestin receptor positive tumors with positron emission tomography Cancer Research 51(7): 1930-1933